Comment on the 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults
- PMID: 38140884
- DOI: 10.1111/jgs.18721
Comment on the 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults
Comment in
-
Reply to: Comment on the 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults.J Am Geriatr Soc. 2024 Feb;72(2):634-635. doi: 10.1111/jgs.18718. Epub 2023 Dec 23. J Am Geriatr Soc. 2024. PMID: 38140880 No abstract available.
Comment on
-
American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults.J Am Geriatr Soc. 2023 Jul;71(7):2052-2081. doi: 10.1111/jgs.18372. Epub 2023 May 4. J Am Geriatr Soc. 2023. PMID: 37139824 Free PMC article.
References
REFERENCES
-
- 2023 American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2023 updated AGS beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):1-30.
-
- Xarelto prescribing information. 2021 https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215859s000lbl.pdf. Accessed September 12, 2023
-
- Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883-891.
-
- Prins MH, Lensing AWA, Bauersachs R, et al. Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVE and PE randomized studies. J Thrombosis. 2013;11:21.
-
- Coleman CI, Antz M, Bowrin K, et al. Real-world evidence of stroke prevention in patients with nonvalvular atrial fibrillation in the United States: the REVISIT-US study. Curr Med Res Opin. 2016;32:2047-2053.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
